Los puntos clave no están disponibles para este artículo en este momento.
These findings suggest that voriconazole may be the best prophylaxis option for patients undergoing HSCT, and posaconazole may be the best prophylaxis option for patients with acute myeloid leukemia or myelodysplastic syndrome.
Wang et al. (Thu,) studied this question.